Oropharyngeal swallowing pathophysiology in patients with idiopathic pulmonary fibrosis: A consecutive descriptive case series.

A. Alamer (Dammam, Saudi Arabia), R. Jones (Newcastle Upon Tyne , United Kingdom), C. Ward (Newcastle Upon Tyne , United Kingdom), M. Drinnan (Newcastle Upon Tyne , United Kingdom), A. Simpson (Newcastle Upon Tyne , United Kingdom), M. Griffin (Newcastle Upon Tyne , United Kingdom), J. Patterson (Liverpool, United Kingdom), I. Forrest (Newcastle Upon Tyne , United Kingdom)

Source: Virtual Congress 2020 – Imaging evaluation of chronic lung diseases
Session: Imaging evaluation of chronic lung diseases
Session type: E-poster session
Number: 3370
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Alamer (Dammam, Saudi Arabia), R. Jones (Newcastle Upon Tyne , United Kingdom), C. Ward (Newcastle Upon Tyne , United Kingdom), M. Drinnan (Newcastle Upon Tyne , United Kingdom), A. Simpson (Newcastle Upon Tyne , United Kingdom), M. Griffin (Newcastle Upon Tyne , United Kingdom), J. Patterson (Liverpool, United Kingdom), I. Forrest (Newcastle Upon Tyne , United Kingdom). Oropharyngeal swallowing pathophysiology in patients with idiopathic pulmonary fibrosis: A consecutive descriptive case series.. 3370

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Management of idiopathic pulmonary fibrosis: selected case reports
Source: Eur Respir Rev 2014; 23:239-248
Year: 2014



Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review
Source: Eur Respir J 2015; 46: 1113-1130
Year: 2015



Impact of BAL lymphocytosis > 15% on the prognosis of chronic idiopathic interstitial pneumonias other than idiopathic pulmonary fibrosis: a retrospective nationwide study based on multidisciplinary discussion
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020


Onset of symptoms in idiopathic pulmonary fibrosis: A case-control study
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016


Does delay in review of newly-diagnosed idiopathic pulmonary fibrosis (IPF) worsen outcomes?
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018


Tsukamurella species isolation in bronchiectasis and chronic obstructive pulmonary disease patients: A retrospective case series
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018



Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry
Source: Eur Respir J 2015; 46: 186-196
Year: 2015



Clinical pattern of idiopathic pulmonary fibrosis in Iran: A retrospective study
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010

The experience of patients with cystic fibrosis during pulmonary exacerbations: a mixed-method study
Source: International Congress 2017 – Nursing practice across respiratory care pathways
Year: 2017

A rare case of idiopathic pulmonary fibrosis in children
Source: Eur Respir J 2007; 30: Suppl. 51, 390s
Year: 2007

PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients
Source: International Congress 2016 – IPF clinical
Year: 2016

Nutritional assessment in patients with idiopathic pulmonary fibrosis: the NUTRIPF study
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


Predictors of objective cough in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019

Initial clinical experience with nintedanib for treatment of idiopathic pulmonary fibrosis (IPF): About 20 cases
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015

Idiopathic pulmonary fibrosis in children (PIPF): a case series from Iran
Source: Eur Respir J 2006; 28: Suppl. 50, 305s
Year: 2006

Clinical outcomes of patients with idiopathic pulmonary fibrosis in clinical practice: Follow-up results of the INSIGHTS-IPF registry
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015



Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features
Source: Eur Respir J 2006; 27: 143-150
Year: 2006



Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020

Familial cases of idiopathic pulmonary fibrosis: Clinical observation
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011


Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study
Source: Eur Respir J 2012; 40: 101-109
Year: 2012